As part of this conversation, Gabrielle Fredman, PhD describes what is meant by the failure of resolution, and the mechanisms that can drive this failure in atherosclerosis. Dr. Fredman ends by outlining the potential for specialized pro-resolving mediator (SPM) therapies in the management of vascular disease.
Gabrielle Fredman, PhD is Associate Professor at Albany Medical College, Department of Molecular and Cellular Physiology.
From the 16th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases, October 2019 in St Petersburg, Florida